JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
50 hedge funds and large institutions have $24.3M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $273K
Holders
50
Holding in Top 10
–
Calls
–
Puts
$273K
Top Buyers
| 1 | +$1.41M | |
| 2 | +$542K | |
| 3 | +$365K | |
| 4 |
AG
Algert Global
San Francisco,
California
|
+$353K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$271K |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$773K | |
| 3 | -$685K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$356K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$297K |